Get started
Author

Kaitlyn Tanner

Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer
2017 · Simon Gebremeskel, Lynnea Lobert, et al. · Cancer Immunology Research · 70
Engineering xylose metabolism in thraustochytrid T18
2018 · Alexandra Merkx-Jacques, Holly Rasmussen, et al. · Biotechnology for Biofuels · 32
PDF
The bacterial pathogen-ubiquitin interface: lessons learned fromShigella
2014 · Kaitlyn Tanner, Peter Brzovic, et al. · Cellular Microbiology · 22
Myopodin isoforms alter the chemokinetic response of PC3 cells in response to different migration stimuli via differential effects on Rho-ROCK signaling pathways
2012 · FuiBoon Kai, Kaitlyn Tanner, et al. · Carcinogenesis · 15
Shigella Effector IpaH9.8 Interacts with Autophagy Transcription Factor ZKSCAN3 and Increases Autophagy During Infection
2016 · Kaitlyn Tanner · DalSpace (Dalhousie University) · 1
Effects of Exercise and Neuromuscular Stimulation on Neuroplasticity and Inflammation in Those With Dementia Risk
2026 · Kaitlyn Tanner, Collis Grace, et al. · Georgia Southern University GS4 Student Scholars Symposium
PDF
Data from Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer
2023 · Simon Gebremeskel, Lynnea Lobert, et al.
Supplementary figure legends from Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer
2023 · Simon Gebremeskel, Lynnea Lobert, et al.
Figure S1 from Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer
2023 · Simon Gebremeskel, Lynnea Lobert, et al.
Figure S2 from Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer
2023 · Simon Gebremeskel, Lynnea Lobert, et al.
Figure S2 from Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer
2023 · Simon Gebremeskel, Lynnea Lobert, et al.
Figure S1 from Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer
2023 · Simon Gebremeskel, Lynnea Lobert, et al.
Data from Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer
2023 · Simon Gebremeskel, Lynnea Lobert, et al.
Abstract 5669: Targeting post-surgical breast cancer metastasis through combining natural killer T cell immunotherapy and low dose chemotherapy
2017 · Simon Gebremeskel, Kaitlyn Tanner, et al. · Cancer Research
Abstract B047: Combining natural killer T cell immunotherapy with chemotherapy induced immunogenic cell death to target post-surgical breast cancer metastasis
2016 · Simon Gebremeskel, Kaitlyn Tanner, et al. · Cancer Immunology Research
Works count: 15
Citation count: 140
H-index: 4
I10-index: 4
Year
Topic
Type